These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3709033)

  • 1. Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin.
    Urien S; Albengres E; Pinquier JL; Tillement JP
    Clin Pharmacol Ther; 1986 Jun; 39(6):683-9. PubMed ID: 3709033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between azapropazone and warfarin.
    McElnay JC; D'Arcy PF
    Br Med J; 1977 Sep; 2(6089):773-4. PubMed ID: 912313
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between azapropazone and warfarin.
    McElnay JC; D'Arcy PF
    Experientia; 1978 Oct; 34(10):1320-1. PubMed ID: 738406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired binding of drugs and endogenous ligands in renal diseases.
    Gulyassy PF; Depner TA
    Am J Kidney Dis; 1983 May; 2(6):578-601. PubMed ID: 6342372
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy.
    Vorum H; Honoré B
    J Pharm Pharmacol; 1996 Aug; 48(8):870-5. PubMed ID: 8887741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azapropazone binding to human serum albumin.
    Fehske KJ; Jähnchen E; Müller WE; Stillbauer A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):159-63. PubMed ID: 7422015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin binding to plasma albumin, measured in patients and related to fatty acid concentrations.
    Larsen FG; Larsen CG; Andersen S; Nørgaard A; Hansen HE; Brodersen R
    Eur J Clin Invest; 1986 Feb; 16(1):22-7. PubMed ID: 3084268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity binding of ethacrynic acid is mediated by the two most important drug binding sites of human serum albumin.
    Fehske KJ; Müller WE
    Pharmacology; 1986; 32(4):208-13. PubMed ID: 3714803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in the binding affinity of warfarin and phenprocoumon to human serum albumin in relation to surgery.
    Vorum H; Jørgensen HR; Brodersen R
    Eur J Clin Pharmacol; 1993; 44(2):157-62. PubMed ID: 8453960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of tryptophan-modified human serum albumin columns for site-specific studies of drug-protein interactions by high-performance affinity chromatography.
    Chattopadhyay A; Tian T; Kortum L; Hage DS
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):183-90. PubMed ID: 9792509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
    MacKichan JJ; Zola EM
    Br J Clin Pharmacol; 1984 Oct; 18(4):487-93. PubMed ID: 6487490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid.
    Hervé F; Rajkowski K; Martin MT; Dessen P; Cittanova N
    Biochem J; 1984 Jul; 221(2):401-6. PubMed ID: 6206846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of late pregnancy on salicylate, diazepam, warfarin, and propranolol binding: use of fluorescent probes.
    Yoshikawa T; Sugiyama Y; Sawada Y; Iga T; Hanano M; Kawasaki S; Yanagida M
    Clin Pharmacol Ther; 1984 Aug; 36(2):201-8. PubMed ID: 6744779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A re-evaluation of the HSA-piroxicam interaction.
    Brée F; Urien S; Nguyen P; Riant P; Albengres E; Tillement JP
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):303-7. PubMed ID: 2088766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nonesterified fatty acids and progesterone on bupivacaine protein binding.
    Coyle DE; Denson DD; Essell SK; Santos DJ
    Clin Pharmacol Ther; 1986 May; 39(5):559-63. PubMed ID: 3698463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The location of drug binding sites in human serum albumin.
    Fehske KJ; Müller WE; Wollert U
    Biochem Pharmacol; 1981 Apr; 30(7):687-92. PubMed ID: 7018498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.